News | February 06, 2015

Patients with Emergency-diagnosed Lung Cancer Report Barriers to Seeing Their GP in the U.K.

Study finds information to suggest ways to ensure that fewer patients have emergency diagnosis of lung cancer

Lung cancer

Image courtesy of Vital Images

February 6, 2015 — Many patients whose lung cancer is diagnosed as an emergency in hospital reported difficulties in previously seeing their general practitioner (GP), according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.

The study, carried out by researchers from the London Cancer Alliance (LCA) and King's College London, investigated around 130 patients who were diagnosed with lung cancer after attending as an emergency at one of seven hospitals in south and west London.

Overall, nearly half of the patients reported that something had put them off to going to the doctor, including difficulty making an appointment, not being able to see their usual doctor, not having confidence in the GP and fear of what the doctor might find. About a fifth of all patients (18 percent) said they had not realized that their symptoms were serious.

A fifth of all patients – who tended to be older, poorer and more fearful of what the doctor might find – delayed going to their doctor with their symptoms for more than 12 weeks.

Three-quarters of the patients had consulted their GP about their symptoms, and one fifth had seen a GP at least three times. Almost a quarter (23 percent) of the patients had already been referred for hospital visits by a GP but many were admitted to hospital before the appointment because they were so unwell.

Lead study author Thomas Newsom-Davis, M.D., LCA Acute Oncology Services pathway chair and consultant medical oncologist at Chelsea and Westminster Hospital, said: "These findings show that we need to work together to improve patient education, ensure that those with possible lung cancer can easily make an appointment to see their GP, and that patients are quickly seen in specialist lung cancer clinics. It's important to pilot ways of ensuring that patients with possible symptoms of cancer can be seen in hospital before they get so ill that they are admitted as an emergency, for example, rapid-access diagnostic clinics."

Lung cancer is the second most commonly diagnosed cancer in the UK. Around 43,500 people are diagnosed each year in the UK with around 35,400 UK deaths from lung cancer annually. Almost 40 percent of patients with lung cancer in England are diagnosed as an emergency in hospital, and have poorer chances of survival.

Robert Rintoul, M.D., chair of NCRI's Lung (Screening and Early Diagnosis) Clinical Studies Subgroup, said: "If lung cancer is diagnosed at an early stage, patients have a much higher chance of surviving the disease. Therefore it's vital that patients recognise possible symptoms early on and are able to get them checked out quickly. This study provides valuable information to suggest ways to help ensure that far fewer patients have an emergency diagnosis of lung cancer, when their disease is likely to be more advanced and treatment is less likely to be successful."

For more information: www.conference.ncri.org.uk/abstracts/2014/abstracts/B123.html


 

 

Related Content

Study Shows Biomarker Panel Boosts Lung Cancer Risk Assessment for Smokers
News | Lung Cancer | July 16, 2018
A four-protein biomarker blood test improves lung cancer risk assessment over existing guidelines that rely solely upon...
Report Finds Identifying Patients for Lung Cancer Screening Not So Simple
News | Lung Cancer | June 18, 2018
New findings in the current issue of The American Journal of Managed Care suggest that getting the right patients to...
Riverain Technologies Issued U.S. Patent for Vessel Suppression Technology
News | Computed Tomography (CT) | June 14, 2018
Riverain Technologies announced that the United States Patent and Trademark Office (USPTO) has awarded the company a...
Zebra Medical Vision Unveils AI-Based Chest X-ray Research
News | Artificial Intelligence | June 08, 2018
June 8, 2018 — Zebra Medical Vision unveiled its Textray chest X-ray research, which will form the basis for a future
Lung Decision Precision
News | Lung Cancer | June 04, 2018
For smokers and former smokers, the threat of lung cancer always lurks in the shadows.
FDA Issues Proposed Order to Reclassify Certain Radiological Medical Image Analyzers
News | Computer-Aided Detection Software | June 01, 2018
The U.S. Food and Drug Administration (FDA) is issuing a proposed order to reclassify certain radiological medical...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
Researchers Use Radiomics to Overcome False Positives in Lung Cancer CT Screening
News | Advanced Visualization | May 29, 2018
A team of researchers including investigators from Mayo Clinic has identified a technology to address the problem of...
ACR Urges Stricter Adherence to Lung Cancer Screening Guidelines
News | Lung Cancer | May 21, 2018
A new statement from the American College of Radiology (ACR) asserts that provider non-compliance to lung cancer...
Matrix Analytics Announces Company Rebrand to Eon
News | Artificial Intelligence | May 16, 2018
Denver-based Matrix Analytics announced the company's rebrand to Eon. The rebrand marks the expansion of Eon's...
Overlay Init